cas 299-35-4|| where to buy 3-((4-Amino-2-methylpyrimidin-5-yl)methyl)-5-(2-mercaptoethyl)-4-methylthiazol-3-ium chloride

Produktname:3-((4-Amino-2-methylpyrimidin-5-yl)methyl)-5-(2-mercaptoethyl)-4-methylthiazol-3-ium chloride

IUPAC Name:3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-5-(2-sulfanylethyl)-1,3-thiazol-3-ium chloride

Packungseinheit	Verfügbarer Vorrat	Preis($)
CM167784-50mg	3-4 Weeks	ǊŢư
CM167784-100mg	3-4 Weeks	ĽȎŉ
CM167784-250mg	3-4 Weeks	ȎǯǊ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 299-35-4 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:299-35-4; Molekulare Formel:C12H17ClN4S2; Schmelzpunkt:-; SMILES-Code:SCCC1=C(C)[N+](CC2=CN=C(C)N=C2N)=CS1.[Cl-]; Dichte:

: Katalognummer:CM167784; Molekulargewicht:316.87; Siedepunkt:; Mdl-Nr.:; Lagerung:

: Thiazoles; Thiazoles are very important functional groups in medicinal chemistry. They act as ligands on a variety of biological matrices. Thiazoles are used in a wide range of therapeutic applications, such as antibacterial, antiretroviral, antifungal, antiallergic, antihypertensive, pain treatment, and to control symptoms of schizophrenia.

: Pyrimidines; Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.